Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Rhea, Elizabeth M.a; b; * | Nirkhe, Surabhia | Nguyen, Stevena | Pemberton, Saraha | Bammler, Theo K.c | Beyer, Richardc | Niehoff, Michael L.d | Morley, John E.d | Farr, Susan A.d | Banks, William A.a; b
Affiliations: [a] Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA | [b] Department of Medicine, University of Washington, Seattle, WA, USA | [c] Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA | [d] Department of Internal Medicine, Saint Louis School of Medicine, St. Louis, MO, USA
Correspondence: [*] Correspondence to: Elizabeth M. Rhea, Veterans Affairs Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA 98108, USA. E-mail: [email protected].
Abstract: Research on intranasal delivery of drugs, peptides, and proteins has grown over the past decade as an alternate way to deliver substrates to the brain. Recent work has shown intranasal (INL) delivery of insulin improves memory and cognition in healthy subjects as well as patients with Alzheimer’s disease (AD) and in AD mouse models. However, the molecular mechanism(s) for the beneficial effect of insulin on memory are still unclear. Using the SAMP8 mouse model of AD, we investigated the impact of INL insulin on protein and gene expression in brain regions including the olfactory bulb, hypothalamus, and hippocampus. We found genes and proteins in the insulin receptor signaling pathway were not activated by the doses tested. However, we did find the expression of genes present in the hippocampus involved in other pathways, especially those related to inflammation, were altered due to age and with a dose of INL insulin previously shown to improve cognition. These alternate pathways could be targets of insulin when delivered via the INL route to aid in memory improvement.
Keywords: Alzheimer’s disease, cognition, hippocampus, insulin, intranasal, RNA sequence analysis
DOI: 10.3233/JAD-190707
Journal: Journal of Alzheimer's Disease, vol. 71, no. 4, pp. 1361-1373, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]